a2z Radiology AI vs Nom Nom

Side-by-side comparison of AI visibility scores, market position, and capabilities

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Nom Nom

EmergingPet Care

Pet Food

Mars-acquired fresh dog and cat food subscription with veterinary science and clinical trial validation; competing with The Farmer's Dog and Ollie for premium DTC pet food market through human-grade ingredients.

AI VisibilityBeta
Overall Score
D36
Category Rank
#6 of 6
AI Consensus
65%
Trend
stable
Per Platform
ChatGPT
29
Perplexity
31
Gemini
43

About

Nom Nom (formerly NomNomNow) is a Nashville-based fresh dog and cat food delivery subscription — acquired by Mars, Incorporated (private, the world's largest pet care company with $8B+ Pedigree/Whiskas/Royal Canin annual revenue) in 2023 — providing pet owners with human-grade, nutritionally balanced meals formulated by board-certified veterinary nutritionists and prepared fresh in USDA-inspected kitchens, delivered weekly or bi-weekly in pre-portioned meal packs calibrated to each pet's age, weight, breed, and health conditions.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.